COBIMETINIB for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,324 adverse event reports in the FDA FAERS database where COBIMETINIB was used for Malignant melanoma.
Most Reported Side Effects for COBIMETINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 412 | 10.1% | 39 | 214 |
| Off label use | 411 | 10.1% | 40 | 65 |
| Rash | 369 | 9.1% | 11 | 166 |
| Pyrexia | 332 | 8.2% | 19 | 228 |
| Death | 231 | 5.7% | 230 | 23 |
| Nausea | 206 | 5.1% | 17 | 105 |
| Fatigue | 198 | 4.9% | 15 | 93 |
| No adverse event | 178 | 4.4% | 0 | 1 |
| Vomiting | 168 | 4.1% | 20 | 108 |
| Acute kidney injury | 133 | 3.3% | 18 | 114 |
| Photosensitivity reaction | 124 | 3.1% | 10 | 44 |
| Asthenia | 119 | 2.9% | 13 | 68 |
| Rash maculo-papular | 118 | 2.9% | 7 | 73 |
| Blood creatine phosphokinase increased | 114 | 2.8% | 5 | 58 |
| Drug reaction with eosinophilia and systemic symptoms | 113 | 2.8% | 6 | 72 |
Other Indications for COBIMETINIB
Metastatic malignant melanoma (898)
Product used for unknown indication (402)
Histiocytosis (98)
Erdheim-chester disease (90)
Plasma cell myeloma (76)
Neoplasm malignant (70)
Neoplasm (68)
Langerhans' cell histiocytosis (56)
Cholangiocarcinoma (53)
Malignant melanoma stage iv (53)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
TALIMOGENE LAHERPAREPVEC (562)